Vital Farms (NASDAQ:VITL) Given New $32.00 Price Target at Lake Street Capital

Vital Farms (NASDAQ:VITL) had its price objective lifted by Lake Street Capital from $26.00 to $32.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s price objective points to a potential upside of 21.03% from the stock’s current price.

Several other equities analysts have also issued reports on the stock. William Blair started coverage on shares of Vital Farms in a report on Wednesday, April 10th. They set an “outperform” rating on the stock. Stifel Nicolaus lifted their price target on shares of Vital Farms from $15.00 to $16.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Finally, TheStreet raised shares of Vital Farms from a “c” rating to a “b-” rating in a report on Monday, March 18th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $20.20.

Vital Farms Stock Performance

Shares of VITL stock opened at $26.44 on Wednesday. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 45.59 and a beta of 0.89. The company’s 50 day moving average is $21.96 and its 200 day moving average is $16.53. The company has a quick ratio of 2.49, a current ratio of 3.00 and a debt-to-equity ratio of 0.05. Vital Farms has a 52-week low of $10.00 and a 52-week high of $27.37.

Vital Farms (NASDAQ:VITL) last issued its quarterly earnings data on Thursday, March 7th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.03. The company had revenue of $135.81 million for the quarter, compared to analyst estimates of $131.10 million. Vital Farms had a net margin of 5.42% and a return on equity of 14.22%. During the same period last year, the company posted $0.04 earnings per share. On average, sell-side analysts anticipate that Vital Farms will post 0.77 EPS for the current fiscal year.

Insiders Place Their Bets

In other Vital Farms news, CEO Russell Diez-Canseco sold 36,948 shares of Vital Farms stock in a transaction on Friday, April 12th. The shares were sold at an average price of $25.07, for a total value of $926,286.36. Following the transaction, the chief executive officer now directly owns 368,753 shares of the company’s stock, valued at $9,244,637.71. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Russell Diez-Canseco sold 36,948 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $25.07, for a total transaction of $926,286.36. Following the sale, the chief executive officer now directly owns 368,753 shares of the company’s stock, valued at $9,244,637.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Jason Dale sold 14,006 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $16.03, for a total transaction of $224,516.18. Following the sale, the chief operating officer now directly owns 48,455 shares in the company, valued at $776,733.65. The disclosure for this sale can be found here. Over the last three months, insiders have sold 260,125 shares of company stock valued at $5,580,996. 30.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Vital Farms

A number of large investors have recently made changes to their positions in the stock. Rice Hall James & Associates LLC grew its holdings in shares of Vital Farms by 82.1% during the first quarter. Rice Hall James & Associates LLC now owns 373,392 shares of the company’s stock valued at $8,681,000 after buying an additional 168,296 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new stake in shares of Vital Farms during the first quarter valued at $656,000. Ranger Investment Management L.P. purchased a new stake in Vital Farms in the fourth quarter valued at $3,016,000. Tower Research Capital LLC TRC boosted its holdings in Vital Farms by 211.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company’s stock valued at $97,000 after purchasing an additional 4,192 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in Vital Farms in the fourth quarter valued at $720,000. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.